ISIN | LU2207278073 |
---|---|
Valorennummer | 57670939 |
Bloomberg Global ID | |
Fondsname | Kieger Impact Healthcare Fund Class A USD Accumulating |
Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fondsanbieter | Kieger AG |
Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
Distributor(en) | |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related companies or issuers worldwide (including Emerging Markets) with a focus on issuers that contribute to the realisation of the healthcare related United Nations Sustainable Development Goals ("SDGs"). No guarantee can be given that the investment objective will be achieved. |
Besonderheiten |
Aktueller Preis * | 84.14 USD | 31.07.2024 |
---|---|---|
Vorheriger Preis * | 84.34 USD | 30.07.2024 |
52 Wochen Hoch * | 90.46 USD | 02.08.2023 |
52 Wochen Tief * | 71.22 USD | 10.11.2023 |
NAV * | 84.14 USD | 31.07.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 85'070'872 | |
Anteilsklassevermögen *** | 80'578'382 | |
Trading Information SIX |
YTD-Performance | -3.55% |
29.12.2023 - 31.07.2024
29.12.2023 31.07.2024 |
---|---|---|
YTD-Performance (in CHF) | +0.65% |
29.12.2023 - 31.07.2024
29.12.2023 31.07.2024 |
1 Monat | +4.65% |
01.07.2024 - 31.07.2024
01.07.2024 31.07.2024 |
3 Monate | +2.77% |
30.04.2024 - 31.07.2024
30.04.2024 31.07.2024 |
6 Monate | +0.06% |
31.01.2024 - 31.07.2024
31.01.2024 31.07.2024 |
1 Jahr | -9.60% |
31.07.2023 - 31.07.2024
31.07.2023 31.07.2024 |
2 Jahre | -8.21% |
02.08.2022 - 31.07.2024
02.08.2022 31.07.2024 |
3 Jahre | -30.49% |
02.08.2021 - 31.07.2024
02.08.2021 31.07.2024 |
5 Jahre | -15.86% |
30.09.2020 - 31.07.2024
30.09.2020 31.07.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Pacira BioSciences Inc | 3.94% | |
---|---|---|
Penumbra Inc | 3.93% | |
ResMed Inc | 3.92% | |
Sage Therapeutics Inc | 3.89% | |
Hikma Pharmaceuticals PLC | 3.87% | |
Organon & Co Ordinary Shares | 3.84% | |
Intra-Cellular Therapies Inc | 3.83% | |
DexCom Inc | 3.69% | |
Allogene Therapeutics Inc | 3.69% | |
Centene Corp | 3.67% | |
Letzte Daten-Aktualisierung | 30.04.2023 |
TER *** | 1.21% |
---|---|
Datum TER *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.17% |
SRRI ***
|
|
Datum SRRI *** | 30.06.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |